Patent Application
20220133639
The invention generally relates to polymer-based nano-structures. More particularly, the invention relates to novel, surface-functionalized, guest-host polymer nano-assemblies and nano-delivery vehicles useful in diverse fields including drug delivery, diagnostics and specialty materials.
Nanoparticles have had a significant impact on a variety of areas such as microelectronics, multiphase catalysis, sensing and therapeutics. (Nanoparticles: From Theory to Application; Schmid, Ed.; Wiley-VCH: Essen, 2004; Zhang, et al. Self-Assembled Nanostructures; Nanostructure Science and Technology Series; Springer: 2002; Nanoparticles: Building Blocks for Nanotechnology; Rotello, Ed.; Springer: 2003; Daniel, et al. 2004 Chem. Rev. 104, 293.) For most applications, facile modulation of the nanoparticle surface is critical in order to obtain appropriate interfacial properties. The ability to encapsulate and release guest molecules within the nanoparticle interior is also required for applications such as sensing and therapeutics.
A platform that affords both surface functionalization and guest encapsulation in a single nanoscopic scaffold is highly desirable. Nanoscale materials, such as metallic or semiconductor nanoparticles and dendrimers, are excellent scaffolds for displaying surface functional groups. (Giljohann, et al. 2010 Angew. Chem. Int. Ed. 49, 3280-3294; Saha, et al. 2012 Chem. Rev. 112, 2739-2779; Khandare, et al. 2012 Chem. Soc. Rev. 41, 2824-2848; Grayson, et al. 2001 Chem. Rev. 101, 3819-3867; Arima, et al. 2012 Pharmaceutics 4, 130-148.) For example, monolayer protection of gold nanoparticles is easily achieved with thiol-bearing molecules due to the high affinity of thiol moiety toward gold nanoparticles. However, these scaffolds generally lack features that allow for favorable non-covalent host-guest interactions. In contrast, amphiphilic molecules readily self-assemble into nanoassemblies, such as micelles and liposomes, which can encapsulate guest molecules within their interior spaces. (Harada, et al. 2006 Progress in Poly. Sci. 31, 949-982; O'Reilly, et al. 2006 Chem. Soc. Rev. 35, 1068-1083; Zhu, et al. 2012 J. Mat. Chem. 22, 7667-7671; Owen, et al. 2012 Nano Today 7, 53-65; Sawant, et al. 2010 Soft Matter 6, 4026-4044; Micheli, et al. 2012 Recent Patents on CNS Drug Discovery 7, 71-86.)
Nevertheless, modifying their surface functional groups are challenging because these modifications often result in changes in the hydrophilic-lipophilic balance that is necessary for retention of the fidelity of the assembly. Surface functionalizable polymeric nanoparticles often require rigorous processing conditions. Additionally, size variations are limited and difficult to achieve and control.
Polymer vesicles, or polymersomes have been generated and extensively investigated as drug delivery vehicles, diagnostics, nanoreactors and artificial organelles. (Tanner, et al. 2011 Acc. Chem. Res. 44, 1039-1049; Vriezema, et al. 2007 Angew. Chem. Int. Ed. 46, 7378-7382; Wang, et al. 2012 Angew. Chem. Int. Ed. 51, 11122-11125; Lomas, et al. 2007 Adv. Mater. 19, 4238-4243; Choucair, et al. 2005 Langmuir 21, 9308-9313; Ben-Haim, et al. 2008 Nano Lett. 8, 1368-1373; Ghoroghchian, et al. 2005 PNAS 102, 2922-2927; Choi, et al. 2005 Nano Lett. 5, 2538-2542; Sanson, et al. 2011 ACS Nano 5, 1122-1140; Ahmed, et al. 2006 J. Control. Releas. 116, 150-158.)
The potential advantages of polymeric vesicle compared with their lipid counterparts arise from the enhanced colloidal stability, tunable membrane thickness and permeability, and engineered surface functionalities. However, a remaining challenge involves the unstable nature of the non-covalently organized supramolecular assembly of the polymersome, which causes morphological changes. The morphological changes can be due to the change in solvent composition during the dialysis to remove organic solvent in polymersome formation process or due to the post-functionalization that changes hydrophilic lipophilic balance (HLB) of the precursor polymer resulting in loss of fidelity of the assembly. (Du, et al. 2009 Soft Matter 5, 3544-3561; Su, et al. 2014 ACS Macro Lett. 3, 534-539.)
Additionally, like other self-assembled systems polymersomes also undergo disassembly upon dilution, solvent exposure and interaction with their surroundings depending on the specific applications. (Savariar, et al. 2008 J. Am. Chem. Soc. 130, 5416-5417.) To address these issues, the formation of vesicle by solvation of polymer in aqueous media followed by the chemical crosslinking can be a good solution. Unfortunately, chemistries developed for polymersome post-functionalization, direct dissolution method and efficient cross-linking chemistry for aqueous solution are all quite limited. (Egli, et al. 2011 J. Am. Chem. Soc. 133, 4476-4483; Opsteen, et al. 2007 Chem. Commun. 30, 3136-3138; Li, et al. 2007 Chem. Commu. 30, 5217-5219; Rosselgong, et al. 2012 ACS Macro Lett. 1, 1041-1045.)
Another challenge for polymersome preparation is to control the size that is critical for their applications. (Harashima, et al. 1996 Adv. Drug Delivery Rev. 19, 425-444.) Although polymersomes with tunable size can be achieved by varying the block length, concentration of copolymers and ratio of solvents, the preparation of vesicle-forming copolymers with complex architectures like block, graft or dendritic copolymer requires demanding synthetic effort even with the aid of the robust polymerization techniques. (Xu, et al. 2009 J. Mater. Chem. 19, 4183-4190; Anraku, et al. 2010 J. Am. Chem. Soc. 132, 1631-1636; Blanazs, et al. 2012 Macromolecules 45, 5099-5107; Zhou, et al. 2004 Angew. Chem. Int. Ed. 43, 4896-4899; Azzam, et al. 2006 Angew. Chem. Int. Ed, 45, 7443-7447; Sun, et al. 2009 ACS Nano 3, 673-681; Wang, et al. 2001 J. Colloid. Interf. Sci. 237, 200-207.)
Capability of facile formation of polymersome from easily accessible polymers with simple architectures will open a new avenue to prepare customized polymersomes. Directed by the potential applications, the “intelligent” polymersomes that are capable of adapting to the environmental changing are really desired. (Bellomo, et al. 2004 Nat. Mater. 3, 244-248; Napoli, et al. 2004 Nat. Mater. 3. 183-189; Yan, et al. 2013 Angew. Chem. Int. Ed. 52, 5070-5073; Liu, et al. 2014 J. Am. Chem. Soc. 136, 7492-7497; Liu, et al. 2006 Angew. Chem. Int. Ed. 45, 3846-3850.)
Thus, there is an urgent need for simplified and reliable approaches to functionalizable polymer nanoparticles and delivery vehicles. Additionally, challenges remain for “intelligent” polymersomes and simple methods to their preparation.
The invention relates to novel, surface-functionalized/functionalizable, guest-host polymer nano-assemblies and nano-delivery vehicles useful in diverse fields including drug delivery, diagnostics and specialty materials. The functionalized/functionalizable polymer nanoparticles exhibit the advantages of surface functionalization capabilities available in dendrimers and metallic nanoparticles as well as the host-guest features presented in micelles and vesicles. Importantly, the nano-assemblies and nano-delivery vehicles of the invention are afforded via simple and reliable approaches.
The invention also relates to novel novel polymer-based cross-linked nanoparticle with vesicular structures, or VesiGel, and methods of their preparation. Herein disclosed is an easy and generally applicable method in which a simple and easily obtained amphiphilic homopolymer electrolyte self-assembles into vesicular structure assisted by a variety of multivalent salts based on a salt-bridging mechanism. The VesiGel disclosed herein have been demonstrated to capture the features including: i) organic solvent free formation; ii) tunable nanoscaled sizes; ii) variable surface functionalities; iii) functionalizable corona and membrane; iv) reversible crosslinking stabilization; v) capable of encapsulating hydrophobic and hydrophilic small molecules as well as proteins; v) stimuli-responsive controlled release of encapsulants.
In one aspect, the invention generally relates to a nano-assembly. The nano-assembly includes: (1) a host crosslinked polymer network having a functionalized surface with one or more functional groups; and (2) a guest molecular cargo non-covalently encapsulated in the host crosslinked polymer network. The host crosslinked polymer network is addressable by a biological, physical or chemical intervention resulting in partial or complete decrosslinking of the host polymer network and release of the guest molecular cargo from the nano-assembly.
In another aspect, the invention generally relates to a composition comprising the nano-assembly disclosed herein.
In yet another aspect, the invention generally relates to a method for controlled delivery of an agent to a target biological site. The method includes: (1) providing a nano-assembly of a host crosslinked polymer network non-covalently encapsulating therein a guest molecular cargo, wherein the host crosslinked polymer network is capable of partial or complete decrosslinking by a biological, physical or chemical intervention resulting in release of the guest molecular cargo from the nano-assembly; (2) delivering the nano-assembly to the target biological site; and (3) causing a biological, physical or chemical intervention resulting in a partial or complete decrosslinking resulting in release of the guest molecular cargo from the nano-assembly.
In yet another aspect, the invention generally relates to a nanoparticle. The nanoparticle includes: (1) a shell of a crosslinked polymer network having a surface functionalized with one or more functional groups; and (2) a core comprising a host polymer network and a guest agent non-covalently encapsulated therein. The core and shell of crosslinked polymer network are independently addressable by a biological, physical or chemical intervention resulting in partial or complete disassembly of the shell and/or the core thereby releasing of the guest agent.
In yet another aspect, the invention generally relates to a polymer-based nanoparticle having vesicular structures stabilized by intraparticular crosslinking, wherein the polymer is an amphiphilic homopolymer comprising a hydrophilic head group and a hydrophobic tail group.
In certain embodiments, the hydrophilic head group is selected from charged functional groups such as amino, ammonium, sulfonium, phosphonium, carboxylate, phosphate, phosphonate, sulfate, and sulfonate, groups and charge-neutral functional groups such as carboxy betaine, sulfo betaine, phosphoryl choline, phosphonyl choline, saccharides, and polyethylene glycol groups and the hydrophobic tail group is selected from linear and branched alkyl chains, linear and branched fluoro-substituted alkyl chains, and alkyl chains containing aromatic or heteromatic functional groups.
In yet another aspect, the invention generally relates to a nano-assembly. The nano-assembly includes: a host crosslinked polymer-based nanoparticle disclosed herein; and a guest molecular cargo non-covalently encapsulated in the host crosslinked polymer-based nanoparticle. The host crosslinked polymer network is addressable by a biological or chemical intervention resulting in partial or complete decrosslinking of the host polymer network and release of the guest molecular cargo from the nano-assembly.
In yet another aspect, the invention generally relates to a method for forming a polymer-based nanoparticle disclosed herein. The method includes: providing an amphiphilic homopolymer by a ring opening reaction; causing self-assembly of the amphiphilic homopolymer, induced or assisted by one or more salt, to form a polymersome comprising vesicle structures; and performing an intra-particular crosslinking on the polymersome resulting in intra- and inter-molecularly crosslinked polymer-based nanoparticle having vesicle structures.
In yet another aspect, the invention generally relates to a method for controlled delivery of a molecular cargo to a target biological site. The method includes: providing a nano-assembly disclosed herein; delivering the nano-assembly to the target biological site; and causing a biological or chemical intervention resulting in a partial or complete decrosslinking resulting in release of the guest molecular cargo from the nano-assembly.
Definitions of specific functional groups and chemical terms are described in more detail below. General principles of organic chemistry, as well as specific functional moieties and reactivity, are described in “Organic Chemistry”, Thomas Sorrell, University Science Books, Sausalito: 2006. It will be appreciated that the compounds, as described herein, may be substituted with any number of substituents or functional moieties.
As used herein, “Cx-Cy” refers in general to groups that have from x to y (inclusive) carbon atoms. Therefore, for example, C1-C6 refers to groups that have 1, 2, 3, 4, 5, or 6 carbon atoms, which encompass C1-C2, C1-C3, C1-C4, C1-C5, C2-C3, C2-C4, C2-C5, C2-C6, and all like combinations. “C1-C20” and the likes similarly encompass the various combinations between 1 and 20 (inclusive) carbon atoms, such as C1-C6, C1-C12 and C3-C12.
As used herein, the term “alkyl”, refers to a hydrocarbyl group, which is a saturated hydrocarbon radical having the number of carbon atoms designated and includes straight, branched chain, cyclic and polycyclic groups. The term “hydrocarbyl” refers to any moiety comprising only hydrogen and carbon atoms. Hydrocarbyl groups include saturated (e.g., alkyl groups), unsaturated groups (e.g., alkenes and alkynes), aromatic groups (e.g., phenyl and naphthyl) and mixtures thereof.
As used herein, the term “Cx-Cy” alkyl refers to a saturated linear or branched free radical consisting essentially of x to y carbon atoms, wherein x is an integer from 1 to about 10 and y is an integer from about 2 to about 20. Exemplary Cx-Cy alkyl groups include “C1-C20 alkyl,” which refers to a saturated linear or branched free radical consisting essentially of 1 to 20 carbon atoms and a corresponding number of hydrogen atoms. Exemplary C1-C20 alkyl groups include methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, dodecanyl, etc.
As used herein, the term “halogen” refers to fluorine (F), chlorine (Cl), bromine (Br), or iodine (I).
As used herein, the term “biological, physical or chemical interventions” includes a change in pH, redox reagent, redox potential, ionic strength, enzymatic activity, protein concentration, light (e.g., UVA, UVB or UVC), heat, or mechanical stress.
As used herein, “VesiGels” refers to polymer-based cross-linked nanoparticle with vesicular structures disclosed herein.
The invention provides surface-functionalized/functionalizable, guest-host polymer nano-assemblies and nano-delivery vehicles useful in diverse fields including drug delivery, diagnostics and specialty materials.
The nano-assemblies and nano-delivery vehicles of the invention can be prepared via simple and reliable synthetic techniques. The nanoparticles of the invention capture the advantages of surface functionalization capabilities available in dendrimers and metallic nanoparticles as well as the host-guest features presented in micelles and vesicles.
In one aspect, the invention generally relates to a nano-assembly. The nano-assembly includes: (1) a host crosslinked polymer network having a functionalized surface with one or more functional groups; and (2) a guest molecular cargo non-covalently encapsulated in the host crosslinked polymer network. The host crosslinked polymer network is addressable by a biological, physical or chemical intervention resulting in partial or complete decrosslinking of the host polymer network and release of the guest molecular cargo from the nano-assembly.
In certain embodiments, the host crosslinked polymer network is a nanogel.
In certain embodiments, the host crosslinked polymer network is formed from a random copolymer via a controlled crosslinking.
In certain embodiments, the polymer network is formed from a homopolymer via a controlled crosslinking.
Depending on the nature of the polymer network and crosslinking, the biological or chemical intervention may be a change in pH, redox reagent, redox potential, ionic strength, enzymatic activity, protein concentration, light, heat, or mechanical stress, which intervention leads to a breaking and/or forming of a chemical bond.
The nano-assembly may take any suitable dimensions, for example, having a diameter from about 3 nm to about 300 nm (e.g., about 3 nm to about 200 nm, about 3 nm to about 100 nm, about 3 nm to about 50 nm, about 3 nm to about 30 nm, about 10 nm to about 300 nm, about 30 nm to about 300 nm, about 50 nm to about 300 nm, about 100 nm to about 300 nm).
The non-covalently encapsulated guest molecular cargo may be present in any suitable amounts, for example, accounting for from about 1 wt % to about 45 wt % (e.g., about 1 wt % to about 35 wt %, about 1 wt % to about 25 wt %, about 1 wt % to about 20 wt %, about 1 wt % to about 15 wt %, about 1 wt % to about 10 wt %, about 5 wt % to about 45 wt %, about 10 wt % to about 45 wt %, about 15 wt % to about 45 wt %, about 20 wt % to about 45 wt %) of the nano-assembly.
The guest molecular cargo may be any suitable material, for example, selected from therapeutic, diagnostic or imaging agents. For example, the guest molecular cargo is a small molecule, a peptide or an oligonucleotide. In certain embodiments, the guest molecular cargo is an antitumor agent.
In certain preferred embodiments, the guest molecular cargo is a hydrophobic molecule.
The functionalized surface of the non-covalently may display one or more reactive groups at any suitable density, for example, from very sparingly (e.g., about 0.1%) to full coverage (e.g., about 100%). Thus, for example, the functionalized surface of the non-covalently may display reactive groups at a density of 1, 2, 5, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100%.
In another aspect, the invention generally relates to a composition comprising the nano-assembly disclosed herein.
In yet another aspect, the invention generally relates to a method for controlled delivery of an agent to a target biological site. The method includes: (1) providing a nano-assembly of a host crosslinked polymer network non-covalently encapsulating therein a guest molecular cargo, wherein the host crosslinked polymer network is capable of partial or complete decrosslinking by a biological, physical or chemical intervention resulting in release of the guest molecular cargo from the nano-assembly; (2) delivering the nano-assembly to the target biological site; and (3) causing a biological, physical or chemical intervention resulting in a partial or complete decrosslinking resulting in release of the guest molecular cargo from the nano-assembly.
Depending on the nature of the polymer network and crosslinking, the biological, physical or chemical intervention is a change in pH, redox reagent, redox potential, ionic strength, enzymatic activity, protein concentration, light, heat, or mechanical stress.
In certain preferred embodiments, the guest molecular cargo is selected from a therapeutic, diagnostic or imaging agent. For example, the guest molecular cargo is a small molecule, a peptide or an oligonucleotide. In certain embodiments, the guest molecular cargo is an antitumor agent.
In certain embodiments, the target biological site comprises a site inside a cell (e.g., a tumor cell).
In certain embodiments, the target biological site comprises a site extracellular to a tumor cell. In certain embodiments, the nano-assembly is preferably taken up by a tumor tissue in a physiological environment.
In yet another aspect, the invention generally relates to a nanoparticle. The nanoparticle includes: (1) a shell of a crosslinked polymer network having a surface functionalized with one or more functional groups; and (2) a core comprising a host polymer network and a guest agent non-covalently encapsulated therein. The shell of crosslinked polymer network is addressable by a biological, physical or chemical intervention resulting in partial or complete dissociation of the shell thereby releasing of the guest agent.
In certain embodiments, the host crosslinked polymer network is formed from a random copolymer via a controlled crosslinking.
In certain embodiments, the host crosslinked polymer network is formed from a homopolymer via a controlled crosslinking.
In certain embodiments, the one or more functional groups are selected from the group consisting of amines, carboxylates, hydroxyl, halides, acyl halides, esters, azides, nitriles, amides, epoxides, aldehydes, furans, alkenes and alkynes.
In certain embodiments, the biological, physical or chemical intervention is a change in pH, redox potential, ionic strength, enzymatic activity, protein concentration, light, heat, or mechanical stress.
For example, certain copolymer-based nanoparticles can be rapidly formed by ultraviolet or visible irradiation without the need to use any chemical crosslinkers or agents. The encapsulated guest molecules can be released by ultraviolet or visible irradiation or in the presence of a chemical stimulus such as glutathione if disulfide-bond-forming moieties (or sulfhydryl groups) are also incorporated into the copolymer structure.
In certain preferred embodiments, the guest molecular cargo is selected from a therapeutic, diagnostic or imaging agent. For example, the guest molecular cargo is a small molecule, a peptide or an oligonucleotide. In certain embodiments, the guest molecular cargo is an antitumor agent.
I. Surface-Functionalized Polymer Nanoparticle Formed from Amphiphilic Copolymers
Unique features of the functionalizable copolymer-based nanoparticles include: (i) the precursor polymer is based on a random copolymer; (ii) the polymer self-assembles in a solvent, which can then be converted to nanoparticle in one step without the need for any additional processing; (iii) the nanoparticle contains a surface functional group, which can be further manipulated easily; (iv) the size of the nanoparticle is tunable; and (iv) the interior of the nanoparticle is capable of sequestering guest molecules.
In certain embodiments, the host crosslinked polymer network is formed from a random copolymer via a controlled crosslinking.
In certain preferred embodiments, the random copolymer has the formula of
wherein
each of Z1 and Z2 is independently
wherein Z′ is selected from O, NH, NR (R=C1-C6 alkyl group or RF);
each of R1 and R2 is independently selected from a hydrogen, C1-C12 alkyl group, or halogen;
each of RL1 and RL2 is independently a single bond or a spacer group;
RF is —H or a functional group;
Rx is a crosslinking group capable of inter- or intra-molecular crosslinking;
Rx′ is an inter- or intra-molecularly crosslinked group; and
i=a·n, j=x·n, and k=b·n−x·n, wherein each of a and b is a positive number with a+b=1, each of n and x is independently an integer from about 0.1% to about 100% of b.
In certain preferred embodiments, each of R1 and R2 is methyl.
In certain preferred embodiments, each of RL1 and RL2 is selected from —(CH2)m—, wherein m is an integer from about 1 to about 15 (e.g., from about 1 to about 10, from about 1 to about 6, from about 1 to about 3, from about 3 to about 6, from about 3 to about 15), and —(CH2CH2—O)q—, wherein q is an integer from about 1 to about 50 (e.g., from about 1 to about 30, from about 1 to about 20, from about 1 to about 10, from about 1 to about 6, from about 1 to about 3, from about 3 to about 10, from about 6 to about 20).
RF can be any suitable functional groups, for example, selected from the group consisting of amines, carboxylates, sulfates, sulfonates, phosphates, phosphonates, hydroxyl, halides, acyl halides, esters, azides, nitriles, amides, epoxides, aldehydes, furans, alkenes and alkynes.
In certain preferred embodiments, RF includes an amine gorup.
In certain preferred embodiments, RF includes an activated carboxylic ester group.
Rx can be any crosslinking group group, for examples, selected from coumarin, alkenes, thiols, reactive disulfides, esters, reactive esters, maleimides, alkynes, furans, aldehydes and epoxides.
A unique aspect of the invention is that the molecular design involves self-assembly of amphiphilic random copolymers. In the aqueous phase, the surface functional groups of such an assembly would be dictated by the hydrophilic moiety of the polymer. Here, for example, the use of a primary amine based monomer as the hydrophilic moiety, combined with a reactive hydrophobic monomer as the crosslinkable moiety, led to a functionalizable polymer nanoparticle. The amphiphilic nature of the nano-assembly also allows for incorporation of guest molecules within the hydrophobic interior of the assembly prior to crosslinking. (
Disclosed herein are the design, synthesis, characterization, and further functionalization of various functionalized polymeric nanoparticles. Primary amines are employed as examples of the surface functional groups. The reactivity of primary amines complements a wide range of functional groups such as alkyl halides, Michael acceptors, carboxylic acid, acid chlorides, activated esters, epoxides, anhydride and aldehydes.
Referring to Scheme 1, polymer 1, a poly(methacrylamide), is derived from the co-polymerization of 2-aminoethylmethacylamide and 3-(9-methylcoumarinoxy)propyl methacrylamide (Scheme 1). This co-polymer self-assembles into an amphiphilic aggregate, where the hydrophilic amino moieties are exposed to the aqueous phase, while the coumarin moieties are tucked in the hydrophobic interior. The propensity of coumarins to undergo photochemically driven [2+2] cylcoaddition reaction (Muthuramu, et al. 1982 J. Org. Chem. 47, 3976; Gnanaguru, et al. 1985 J. Org. Chem. 50, 2337-2346; He, et al. 2011 Soft Matter, 7, 2380-2386; Trenor, et al. 2004 Chem. Rev. 104, 3059-3078; Raghupathi, et al. 2011 Chem. Eur. J. 17, 11752-11760) was utilized to achieve the targeted polymer nanoparticles.
To synthesize the targeted polymer 1, the precursor random copolymer, which contains 30% of N-Boc-aminoethylmethacrylamide and 70% of 3-(9-methylcoumarinoxy)propylmethacrylamide was first synthesized; this polymer was prepared by reversible addition-fragmentation chain transfer (RAFT) polymerization. The Boc group was deprotected using trifluoroacetic acid in dichloromethane to yield the random copolymer 1. An aqueous solution of this polymer forms an aggregate of ˜22 nm at 1 mg/mL concentration, as discerned by dynamic light scattering (DLS). This solution was then irradiated at 365 nm for 10 minutes to generate the crosslinked nanoparticle. Several features of this reaction are noteworthy: (i) the intensity of the absorption peak centered at 320 nm, which corresponds to the coumarin moiety, reduces within this irradiation time—confirming the photochemical reaction of the coumarin moiety; (ii) the size of the nanoparticle is the same as the aggregate, suggesting that the coumarin dimerization process is exclusively intra-aggregate—note that inter-aggregate reactions would result higher nanoparticle sizes; (iii) there is no discernible nanoaggregate of the uncrosslinked polymer in 10% water in DMSO, while the crosslinked nanoparticle's size is slightly increased in this solvent mixture (
Hydrophobic dye molecules, such as 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate (DiI) or 3,3′-dioctadecyloxacarbocyanine perchlorate (DiO) were encapsulated in the polymer aggregates successfully and guest molecules were retained in the interiors of nanoparticles after photoinduced crosslinking (
The versatility of the amine functionality provides a ready handle for various surface functionalizations of the nanoparticles. First, amines were reacted with an activated ester and a cyclic anhydride to provide amides with complementary surface characteristics. Reaction of the amine-functionalized nanoparticles with a peg-2000 NHS ester converted the positively charged surface of the polymer nanoparticle to a charge neutral surface, while the reaction with succinic anhydride should convert the charge to negative. Zeta potential measurements of the reactants and the products confirmed surface charge modification (
Second, the nanoparticles were modified by a NHS ester (of lauric acid) and an isocyanate (dodecyl). The size of the nanoparticles stayed similar after modification, which was confirmed by TEM (
Next, the surface functionalization was monitored by FTIR. The nanoparticles were reacted with the NETS-ester of azidoacetic acid. The FTIR spectrum of modified nanoparticles showed the appearance of a peak at 2100 cm′, characteristic of the azido group, with the concurrent disappearance of the NETS ester peaks at 1812 cm−1 and 1783 cm−1 (
The relative fluorescence was used to ascertain the extent of surface functionalization. Nanoparticles were first reacted with molecules with different amine-reactive functional groups (pentafluorophenol (PFP) ester, NHS ester, epoxide, and isocyanate). The extent of functionalization was analyzed by comparing the fluorescence from the functionalized amine nanoparticles and the unreacted amine nanoparticle. The fluorescence from three of the functionalized nanoparticles (PFP ester, NHS ester, and isocyanate) was found to be similar to that found with the negative control, indicating that the reaction was quantitative in these cases (
Experiments were performed to investigate the tuning of the nanoparticle sizes. While variations such as polymer MW, concentration, and monomer ratio could afford different aggregate sizes, a simpler variation with the same polymer was also studied as a way to tune the nanoparticle sizes.
The pH of the solution and the ensuing variation the hydrophilic-lipophilic balance of the polymer was studied. Aqueous solutions of polymer 1 at different pH were prepared. The polymer precipitates out at pH˜9, consistent with the pKa of amine groups. Also observed was that the aggregate sizes were not significantly different between pH 3.0 and 6.5. Interestingly, the greatest size differences were observed with subtle pH changes between 7.0 and 8.5, indicating that subtle changes in the degree of protonation of the amines lead to significant size differences. This is presumably due to the difference in hydrophilic lipophilic balance of the polymer at these pHs. These differences can be utilized to systematically tune the size of the nanoparticles by photochemically locking these aggregates, as shown in
Although the fluorescamine assay showed that all the accessible amines can be utilized for surface decoration, it is important to investigate the percentage of amines in the polymer nanoparticle that are inherently accessible. Fluorescamine assay was carried out in 1:3 water/DMSO mixture, in which no aggregation was observed for the non-crosslinked polymer. The fluorescence generated from the uncrosslinked polymer was utilized as a true indicator of the amine moieties available in the polymer. Evaluation of nanoparticles of different sizes, using this as the standard, indicated that nearly all the amine moieties seem to be available at a particle size of 22 nm. However, only 85% and 65% of the amine moieties were available for functionalization in 45 nm and 118 nm particles respectively (
Thus, the versatile polymer nanoparticles provide a number of key advantages as they (i) display versatile functional groups on its surface, which can be further manipulated with a variety of complementary reactive moieties; (ii) are capable of non-covalently binding hydrophobic guest molecules; (iii) afford size tunability by simply altering the pH at which the nanoparticle is synthesized; (iv) have a very high percentage of the accessible surface moieties at smaller sizes. Overall, the simplicity and versatility of the surface functionalizable soft nanoparticles with host-guest capabilities have implications in a variety of applications from materials to biology.
All chemicals and reagents were purchased from commercial sources and were used as received, unless otherwise mentioned. 1H-NMR spectra were recorded on a 400 MHz Bruker NMR spectrometer using the residual proton resonance of the solvent as the internal standard. 13C-NMR spectra were recorded on a 400 MHz Bruker NMR spectrometer using carbon signal of the deuterated solvent as the internal standard. 19F-NMR spectra were collected on a 300 MHz Bruker NMR spectrometer. Molecular weights of the polymers were estimated by gel permeation chromatography (GPC) using PMMA standard with a refractive index detector. Dynamic light scattering (DLS) and zeta potential were determined by Nano-ZS (Malvern Instrument) Zetasizer. The fluorescence spectra were obtained from a JASCO FP-6500 spectrofluorimeter. UV-visible absorption spectra were collected using a Cary 100 spectrophotometer. FTIR spectra were recorded on a Perkin Elmer spectrometer. Contact angles of water were examined on a Ramé-Hart telescopic goniometer. Transmission electron microscopy (TEM) images were taken from JEOL 100CX at 100 KV.
Di-tert-butyl dicarbonate (8.0 g, 36.7 mmol) was dissolved in chloroform (50 mL) and added dropwise to a solution of ethylenediamine (13.2 g, 220 mmol) in chloroform (250 mL) at 0° C. The mixture was allowed to warm to room temperature. After stirring for 12 hrs, the reaction crude was filtered and washed with chloroform. The filtrates were collected and the solvent was evaporated. The crude was re-dissolved in ethyl acetate and washed with brine (3×100 mL) and water (100 mL). The organic solution was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford N-Boc ethylenediamine (2.97 g, 51%) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ: 4.95 (bs, 1H), 3.20 (q, 2H), 2.82 (t, 2H), 1.99 (s, 2H). (Roy, et al. 2012 ACS Macro Lett. 1, 529-532.)
To a solution of N-Boc-ethylenediamine (2.0 g, 12.5 mmol) in 20 mL of dry dichloromethane was added 1.5 g (15.0 mmol) of triethylamine and the mixture was cooled in an ice-bath. To this cold mixture, a solution of methacryloyl chloride (1.3 g, 12.5 mmol) in 10 mL dichloromethane was added dropwise with continuous stirring. After the addition, the reaction mixture was stirred at room temperature for 6 hr. The stirring was stopped and the reaction mixture was washed with 3×30 mL distilled water and then with 30 mL of brine. The organic layer was collected, dried over anhydrous Na2SO4 and concentrated to get the crude product as a white solid. It was purified by column chromatography using silica gel as stationary phase and mixture of ethyl acetate/hexane as eluent. Yield: 2.52 g (88%). 1H NMR (400 MHz, CDCl3) δ: 6.70 (bs, 1H), 5.75 (s, 1H), 5.33 (s, 1H), 4.92 (bs, 1H), 3.41 (q, 2H) 3.33 (q, 2H), 1.96 (s, 3H), 1.44 (s, 9H). (Sun, et al. 2007 Chem. Eur. J. 13, 7701-7707.)
To a solution of 3-aminopropanol (2.0 g, 26.6 mmol) in chloroform (50 mL) was added di-tert-butyl dicarbonate (7.0 g, 31.9 mmol) at 0° C. and stirred for 6 hrs at room temperature. Chloroform was evaporated and the residue was re-dissolved in ethyl acetate and washed with saturated NaHCO3 aqueous solution (100 mL) and brine (2×100 mL) The organic solution was dried over anhydrous Na2SO4, filtered and concentrated in vacuo to afford N-boc-3-aminopropanol (4.5 g, 97% yield). 1H NMR (400 MHz, CDCl3) δ: 3.66 (t, 2H), 3.29 (t, 2H), 1.66 (p, 2H), 1.44 (s, 9H). (Mehlich, et al. 2011 Org. Biomol. Chem. 9, 4108-4115.)
N-boc-3-aminopropanol (4.0 g, 22.8 mmol) was dissolved in 100 mL of dry dichloromethane and 2.7 g (27.4 mmol) of triethylamine was added to it. To this mixture, a solution of p-toluenesulfonyl chloride (5.2 g, 27.4 mmol) and 4-dimethylaminopyridine (catalytic amount) in 20 mL dry dicholoromethane was added. The reaction mixture was allowed to stir at room temperature overnight. Solvent was evaporated to get the crude product, which was purified by flash column chromatography using silica gel as stationary phase and mixture of ethyl acetate/hexane as eluent. Yield: 4.46 g (59%). 1H NMR (400 MHz, CDCl3) δ: 7.80 (d, 2H), 7.36 (d, 2H), 4.10 (t, 2H), 3.16 (t, 2H), 2.45 (s, 3H), 1.84 (p, 2H), 1.42 (s, 9H). (Simoni, et al. 2012 J. Med. Chem. 55, 9708-9721.)
In a two-neck round bottom flask, compound 3b (3.0 g, 9.1 mmol) was mixed with 4-methylumbelliferone (1.76 g, 10.0 mmol), K2CO3 (1.38 g, 10.0 mmol), and 18-crown-6 (0.48 g, 1.82 mmol) in acetone (300 mL) under argon atmosphere. The reaction mixture was refluxed for 12 hours. Then, the crude reaction mixture was filtered and washed with acetone. The filtrates were collected and the solvent was evaporated. The crude was then poured into water and extracted with ethyl acetate (3×100 mL). The organic layers were dried over anhydrous Na2SO4, filtered, and concentrated in vacuo. The crude product was purified by flash column chromatography using silica gel as stationary phase and mixture of ethyl acetate/hexane as eluent. Yield: 2.36 g (78% yield). 1H NMR (400 MHz, CDCl3) δ: 7.48 (d, 1H), 6.84 (dd, 1H), 6.80 (d, 1H), 6.13 (s, 1H), 4.73 (bs, 1H), 4.07 (t, 2H), 3.34 (q, 2H), 2.39 (s, 3H), 2.01 (p, 2H), 1.44 (s, 9H). 13C NMR (400 MHz, CDCl3) δ: 162.0, 161.5, 156.1, 155.4, 152.7, 125.7, 113.8, 112.7, 112.2, 101.58, 79.8, 66.3, 38.0, 29.7, 28.5, 18.8.
To deprotect the N-boc amine functionality, compound 3 (2.36 g, 7.1 mmol) was dissolved in 10 mL of 1:1 v/v dichloromethane/trifluoroacetic acid mixture. After stirring at room temperature for 2 hrs, solvent mixture was removed by evaporation, and the oil residue was rinsed two times with diethyl ether (20 mL). The resultant precipitate was collected and dried in vacuo. To a solution of the dried precipitate in 50 mL of dry dichloromethane was added 2.15 g (21.3 mmol) of triethylamine and the mixture was cooled in an ice-bath. To this cold mixture, a solution of methacryloyl chloride (0.82 g, 7.8 mmol) in 10 mL dichloromethane was added drop-wise with continuous stirring. After the addition, the reaction mixture was stirred at room temperature for 6 hrs. The reaction mixture was then washed with 3×30 mL distilled water and then with 30 mL of brine. The organic layer was collected, dried over anhydrous Na2SO4 and concentrated to get the crude product as a yellow solid. It was purified by column chromatography using silica gel as stationary phase and mixture of ethyl acetate/hexane as eluent. Yield: 1.18 g (55%). 1H NMR (400 MHz, CDCl3) δ: 7.50 (d, 1H), 6.84 (dd, 1H), 6.80 (d, 1H), 6.19 (bs, 1H), 6.14 (s, 1H), 5.71 (s, 1H), 5.34 (s, 1H), 4.12 (t, 2H), 3.55 (q, 2H), 2.39 (s, 3H), 2.10 (p, 2H), 1.97 (s, 3H); 13C NMR (400 MHz, CDCl3) δ: 168.7, 161.8, 161.4, 155.3, 152.7, 140.0, 125.7, 119.8, 113.8, 112.4, 112.1, 101.6, 67.0, 37.5, 28.9, 18.8.
A mixture of 4-cyano-4-(phenylcarbonothioylthio)pentanoic acid (7.8 mg, 0.028 mmol), Boc-AEMA (194 mg, 0.85 mmol), CPMA (600 mg, 1.99 mmol) and AIBN (0.92 mg, 0.0019 mmol) was dissolved in DMF (10 ml) and degassed by performing three freeze-pump-thaw cycles. The reaction mixture was sealed and then heated with a pre-heated oil bath at 75° C. for 12 h. The resultant mixture was precipitated in ethyl acetate (200 mL) to remove unreacted monomers. The precipitate was further dissolved in dichloromethane (5 mL) and re-precipitated in ethyl acetate (200 mL) to yield purified random copolymer as a yellow solid. Yield: 21%. 1H NMR (400 MHz, CDCl3/MeOD) δ: 6.8-7.4, 6.5-6.8, 5.8-6.0, 3.8-4.1, 3.0-3.4, 2.1-2.4, 1.5-2.0, 1.2-1.4, 0.7-1.2. GPC (THF) Mn: 3000 Da. PDI: 1.3. The molar ratio between two blocks was determined by integrating the Boc group protons in Boc-AEMA and an aromatic proton in the coumarin and found to be 3:7 (Boc-AEMA:CPMA). To remove the Boc groups, the resulting random copolymer was dissolved in 10 mL of 1:1 v/v trifluoroacetic acid/dichloromethane mixture and stirred overnight at room temperature. Solvent mixture was then removed by evaporation, and the oil residue was rinsed three times with diethyl ether. The resultant precipitate was collected and dried overnight in vacuum to afford random copolymer 1. Yield: 87%. 1H NMR (400 MHz, DMSO-d6) δ: 7.3-8.2, 6.7-7.1, 6.0-6.2, 3.9-4.2, 3.0-3.3, 2.7-2.9, 2.2-2.4, 1.5-2.1, 0.7-1.2. Complete disappearance of the methyl proton signal of the Boc group at 1.2-1.4 ppm confirmed that all the Boc groups have been removed.
To a solution of sodium azide (2.3 g, 36 mmol) in water (50 mL) was added bromoacetic acid (1.0 g, 7.2 mmol) slowly. The reaction mixture was stirred overnight at room temperature. The reaction was quenched with 1 M of HCl aqueous solution. The crude material was mixed with water (50 mL) and extracted with ethyl acetate (3×100 mL). The organic solution was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford azidoacetic acid (0.39 g, 54% yield). 1H NMR (400 MHz, CDCl3) δ: 10.62 (bs, 1H), 3.98 (s, 2H). (Ghosh, et al. 2012 Chem. Eur. J. 18, 2361-2365.)
To a solution of [2-(2-methoxyethoxy)ethoxy]acetic acid (1 equivalent) and pentafluorophenol (1.2 equivalent) in dry dichloromethane was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.2 equivalent) and catalytic amount of 4-dimethylaminopyridine at 0° C. The reaction mixture was stirred for 6 h at room temperature. The reaction mixture was washed with saturated NaHCO3 aqueous solution and then with brine. The organic solution was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford the crude product. It was purified by column chromatography using silica gel as the stationary phase and mixture of ethyl acetate/hexane as eluent. Yield: 50%. 1H NMR (400 MHz, CDCl3) δ: 4.54 (s, 2H), 3.83 (m, 2H), 3.74 (m, 2H), 3.65 (m, 2H), 3.57 (m, 2H), 3.38 (s, 3H). 19F NMR (300 MHz, CDCl3) δ: −152.5 (2F), −157.3 (1F), −161.9 (2F).
To a solution of carboxylic acid (1 equivalent) and N-hydroxysuccinimide (1.2 equivalent) in dry dichloromethane was added 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (1.2 equivalent) at 0° C. and stirred for 12 hours at room temperature. The stirring was stopped and the reaction mixture was washed with saturated NaHCO3 aqueous solution and then with brine. The organic solution was dried over anhydrous Na2SO4, filtered and concentrated under reduced pressure to afford the N-hydroxysuccinimide ester.
Synthesis of PEG2000 NHS ester was done in dry DMF and the crude reaction mixture was directly taken to next step without any purification.
Yield: 61%. 1H NMR (400 MHz, CDCl3) δ: 4.24 (s, 2H), 2.88 (s, 4H). (Ghosh, et al. 2012 Chem. Eur. J. 18, 2361-2365)
Yield: 71%. 1H NMR (400 MHz, CDCl3) δ: 2.84 (s, 4H), 2.60 (t, 2H), 1.74 (p, 2H), 1.40 (p, 2H), 1.20-1.35 (m, 14H), 0.88 (t, 3H). (Kapdi, et al. 2013 New J. Chem. 37, 961-964)
1H NMR (400 MHz, CDCl3) δ: 2.84 (s, 4H), 2.60 (t, 2H), 1.74 (p, 2H), 1.17-1.48 (m, 12H), 0.88 (t, 3H). (Schulze, et al. 2004 Adv. Synth. Catal. 346, 252-256)
50 μL of 1 mg/mL DiO/DiI (in acetone) was added to a vial, followed by evaporating the acetone with mild blow of air. To this was added 2 mL of nanoparticle solution (1 mg/mL) and sonicated at room temperature for 2 hrs. The resultant mixture was then passed through 0.22 μm filter to remove the non-encapsulated DIO/DiI, followed by stirring the solution at room temperature overnight to remove any residual acetone present in the solution. This stock solution was accordingly diluted with milliQ water (pH 3) to achieve required concentration of the nanoparticles.
To 1 mL of nanoparticle stock solution (1 mg/mL) at basic pH was added the functionalization agents (10 equivalents) dissolved in DMF. After stirring overnight at room temperature, the excess functional group reagents were removed by dialysis. For the functionalization with succinic anhydride, the reaction was done in 0.1 M NaCl solution to minimize the aggregation of opposite charge nanoparticles that could prevent the reaction from going to completion.
The reaction mixtures were first dialyzed in acetone to remove excess reagents and then were switched to aqueous medium. Solutions after dialysis were accordingly diluted with milliQ water to achieve a final concentration of 0.35 mg/mL. All solutions were adjusted to pH 7.1 and then filtered through a 0.22 μm filter before performing surface charge measurements.
To prepare samples for contact angle measurements, stock solution of nanoparticles dissolved in water and dodecyl-functionalized nanoparticles dissolved in dichloromethane were dropped onto a silicon slides and dried at room temperature overnight.
Emission spectra were recorded on a JASCO (FP-6500) spectrofluorimeter using quartz cuvettes. To 100 μL of nanoparticle (1 equivalent) stock solution at basic pH, functional groups (3 equivalents) dissolved in DMSO (800 μL) were added and stirred overnight at room temperature. Fluorescamine (10 equivalents) dissolved in DMSO (100 μL) was then added and stirred for another 2 h at room temperature. All solutions were directly taken to the spectrofluorimeter for measurement without further purification. The emission spectra for fluorescamine-amine adduct were recorded by exciting at 390 nm, with both excitation and emission bandwidths set at 3 nm.
Different aliquots of nanoparticle (200 μg/mL) were pipetted into a 96 well microplate in triplicates. Different volumes of water and DMSO were added to adjust the final water/DMSO (1:2, v:v) volume to 150 μL. The microplate was placed on a microplate shaker and 50 μl of 3.6 mM (1 mg/mL) fluorescamine dissolved in DMSO was added to each well. Following the addition of fluorescamine the plate was shaken for one minute and then allowed to stand at room temperature for 2 h. The fluorescence was then determined using a SpectraMax M5 plate reader with a 400 nm excitation filter and a 460 nm emission filter. The sensitivity setting was at 6 and the data collected from the top.
100 μL aliquots of nanoparticle (200 μg/mL) were pipetted into a 96 well microplate in triplicates, followed by addition of different equivalents of capric acid NHS ester dissolved in DMSO to each well. Different volumes of water and DMSO were added accordingly to adjust the final water/DMSO (1:2, v:v) volume to 150 μL. The microplate was allowed to stay at room temperature for 6 hours during which it was shaken on a microplate shaker for the frequency of one minute per hour (
2 mL polymer solutions (1 mg/mL) in scintillation vials were adjusted to the required pH using NaOH and HCl aqueous solution. After sonicating for 2 min, all solutions were irradiated under UV light (365 nm) for 10 min to crosslink the polymers. The nanoparticle solutions were dialyzed in milliQ water to remove residual DMSO. All nanoparticle solutions were adjusted to pH 3 and then filtered through a 0.22 μm filter before performing dynamic light scattering measurements.
II. Surface-Functionalized Polymer Nanoparticles Self-Assembled from Amphiphilic Homopolymers
Amphiphilic homopolymers have been shown to have predictable solution self-assembly behavior and applications in peptide extraction and guest delivery. Although it is relatively easily to homopolymerize an amphiphilic monomer, the multistep synthesis of monomer itself is laborious. A new methodology with a simple polymer preparation is strongly desired that can profoundly enhance the application of amphiphilic polymers.
In yet another aspect, the invention generally relates to a polymer-based nanoparticle having vesicular structures stabilized by intraparticular crosslinking, wherein the polymer is an amphiphilic homopolymer comprising a hydrophilic head group and a hydrophobic tail group.
In certain embodiments, the hydrophilic head group is selected from charged functional groups such as amino, ammonium, sulfonium, phosphonium, carboxylate, phosphate, phosphonate, sulfate, and sulfonate groups and charge-neutral functional groups such as carboxy betaine, sulfo betaine, phosphoryl choline, phosphonyl choline, saccharides, and polyethylene glycol groups and the hydrophobic tail group is selected from linear and branched alkyl chains, linear and branched fluoro-substituted alkyl chains, and alkyl chains containing aromatic or heteromatic functional groups
In certain embodiments, the intraparticular crosslinking is via a group selected from pyrdinyl disulfide, activated esters, coumarin derivatives, alkynes or alkenes along with thiols, maleimdes with thiols, amines and epoxides, amines, thiols or alcohols along with perforophenyl esters, and alkynes along with azides. In certain embodiments, the amphiphilic homopolymer is a cationic homopolymer. In certain embodiments, the cationic homopolymer includes one or more groups selected from amino, ammonium, sulfonium, phosphonium, pyridinium, imidazolium and other heteroaromatic cationic functional groups. In certain embodiments, the amphiphilic homopolymer is an anionic homopolymer. In certain embodiments, the anionic homopolymer includes one or more groups selected from carboxylate, phosphate, phosphonate, sulfate, and sulfonate groups. In certain embodiments, the amphiphilic homopolymer is a charge-neutral homopolymer. In certain embodiments, the charge-neutral homopolymer is selected from carboxy betaine, sulfo betaine, phosphoryl choline, phosphonyl choline, saccharides, and polyethylene glycol groups.
In certain embodiments, the nanoparticle is surface functionalized. In certain embodiments, the nanoparticle comprises one or more surface functional groups, for example, selected from the group consisting of amines, carboxylates, hydroxyl, halides, acyl halides, esters, azides, nitriles, amides, epoxides, aldehydes, furans, alkenes and alkynes. In certain embodiments, the surface functionalization results in the surface being functionalized by one or more groups selected from polyethylene glycol, amines, carboxylates, epoxides, activated esters, thiols, dopamines, and zwitterionic functional groups. In certain embodiments, the surface functionalization results in the surface being functionalized by peptides (including proteins and antibodies), nucleic acids (including aptamers), and small or large molecule ligands (including targeting ligands with desired binding specificity and selectivity).
In certain embodiments, the intraparticular crosslinking of the polymer-based nanoparticle is addressable by a biological or chemical intervention resulting in partial or complete disassembly of the polymer-based nanoparticle. In certain embodiments, the biological or chemical intervention is a change in pH, redox reagent, redox potential, ionic strength, enzymatic activity, protein concentration, light, heat, or mechanical stress.
In yet another aspect, the invention generally relates to a nano-assembly. The nano-assembly includes: a host crosslinked polymer-based nanoparticle disclosed herein; and a guest molecular cargo non-covalently encapsulated in the host crosslinked polymer-based nanoparticle. The host crosslinked polymer network is addressable by a biological or chemical intervention resulting in partial or complete decrosslinking of the host polymer network and release of the guest molecular cargo from the nano-assembly.
In certain preferred embodiments, the nano-assembly is a nanogel. In certain embodiments, the non-covalently encapsulated guest agent accounts for from 0.1 wt % about to about 45 wt % of the nanoparticle. In certain embodiments, the guest molecular cargo is selected from a therapeutic, diagnostic or imaging agent. In certain embodiments, the guest molecular cargo is a small molecule. In certain embodiments, the guest molecular cargo is a peptide (e.g., a polypeptide, a protein, an antibody). In certain embodiments, the molecular cargo is an oligonucleotide (e.g., DNA or RNA). In certain embodiments, the molecular cargo is an antitumor agent.
In yet another aspect, the invention generally relates to a method for forming a polymer-based nanoparticle disclosed herein. The method includes: providing an amphiphilic homopolymer by a ring opening reaction; causing self-assembly of the amphiphilic homopolymer, induced or assisted by one or more salt, to form a polymersome comprising vesicle structures; and performing an intraparticular crosslinking on the polymersome resulting in intramolecularly crosslinked polymer-based nanoparticle having vesicle structures.
Any suitable salt may be used to induce or assist the formation of the polymersome. In certain embodiments, the salt is one or more of Na2SO4, Na2S2O3, and Na2SO3, Na2HPO4. Na3PO4, and similar multivalent anions with various counterions. In certain embodiments, the salt is one or more of MgCl2, CaCl2, BaCl2, BeCl2, ZnCl2, CuCl2, BiCl3, and similar multivalent cations with various counterions.
In yet another aspect, the invention generally relates to a method for controlled delivery of a molecular cargo to a target biological site. The method includes: providing a nano-assembly disclosed herein; delivering the nano-assembly to the target biological site; and causing a biological or chemical intervention resulting in a partial or complete decrosslinking resulting in release of the guest molecular cargo from the nano-assembly.
In certain preferred embodiments, the homopolymer has the formula of
wherein Z3 is
wherein Z′ is selected from O, NH, NR (R=C1-C6 alkyl group or RF);
R3 is selected from a hydrogen, C1-C12 alkyl group, or halogen;
RL3 is CR4, N or a trivalent group, wherein R4 is selected from a hydrogen, C1-C12 alkyl group, or halogen;
RF is —H or a functional group;
Rx is a crosslinking group capable of inter- or intra-molecular crosslinking or an inter- or intra-molecularly crosslinked group; and r is an integer from about 10 to about 1000.
In certain preferred embodiments, R3 is methyl.
In certain preferred embodiments, RL3 is CH.
The trivalent group may be any suitable group. A trivalent group may include a linear or cyclic portion, serving as a spacer or linker, leading to the trivalent branching point. The branching may be at a single atom or may be at different atoms, for example, three branches from a cyclic or a linear scaffold.
RF can be any suitable functional groups, for example, RF is selected from the group consisting of amines, carboxylates, hydroxyl, halides, acyl halides, esters, azides, nitriles, amides, epoxides, aldehydes, furans, alkenes and alkynes.
In certain preferred embodiments, RF is an amine.
In certain preferred embodiments, RF is an activated carboxylic ester.
Rx can be any crosslinking group group, for examples, selected from coumarin, alkenes, thiols, reactive disulfides, alkynes, furans, aldehydes and epoxides. In certain embodiments, Rx may be selected to be suitable for and provide chemical reactivities, for example, to incorporate functional diversity.
r can be an integer from about 10 to about 1000 (e.g., from about 10 to about 800, from about 10 to about 500, from about 10 to about 300, from about 10 to about 100, from about 10 to about 50, from about 50 to about 800, from about 100 to about 800, from about 200 to about 800).
Unique features of the functionalizable homopolymer-based nanoparticles include a rapid synthesis method affording targeted amphiphilic polymer within 2 to 3 steps from monomer. The functional polymers can be facilely achieved because the fidelity of thiolactone chemistry makes it possible to introduce various functionalities to the polymer by reacting with amino containing functional molecules. It is also worth noting that the chemistry also provides an avenue to incorporate a secondary functionality simultaneously based on thiol chemistry.
The amphiphilic homopolymer was achieved by post-polymerization functionalization, shown in
Examples of amphiphilic homopolymers include:
The driving force for the solution assembly of amphiphilic polymer is hydrophilic lipophilic balance (HLB), which offers an opportunity for us to manipulate the self-assembly of polymer. The polymer precursors have carboxylic acid or amine functionalities which are involved in protonation-deprotonation equilibrium. By varying the pH of polymer solution, the extent to which the functionalities are ionized can be tuned to shift the hydrophilic lipophilic balance. As a result of changing in HLB, the polymer forms nano-assembly with different sizes in aqueous solution (
An alternate way to change the hydrophilicity of ammonium or carboxylate functionalities involves interaction with counter ions. A complementary divalent or trivalent counter ion was employed to polymer solution to form intra-particle salt bridges transiently crosslinking the polymer assembly. Various concentrations of counter ions were added to tune the degree of crosslinking density to tune the size of nanoparticles (
The binding affinity of counter ion pairs is quite different from each other, which suggests that the type of counter ions can regulate the self-assembly of polymer to different extent. A series of counter ions are shown that can tune the size of polymer nano-assembly in
Oligoethylene glycol containing polymers are well known for their LCST behaviors. It is no surprise that oligoethylene glycol containing neurtal amphiphilic homopolymers also have LCST behavior. However, the LCST behavior can be utilized to control the size of the nanoassembly (
A series of salt have Hofmeister effect on oligoethylene glycol containing polymer have been demonstrated. Here, salt was used to manipulate the assembly of the amphiphilic homopolymer. The size of the nanoassembly was found to increase when salt concentration is increased (
Regarding the application of nano-assembly, structural and morphological stability of the assembly are highly desired. In order to stabilize the nano-assembly, chemical cross-linking was used to covalently stabilize the nano-assembly via the addition of DTT. The addition of DTT results in the formation of disulfide bond inside the nano-assembly locking the nano-assembly. The approach applied to regulate the self-assembly of amphiphilic homopolymer can be translated to prepare the cross-linked particles. By varying pH, salt concentration, salt species and polymer solution temperature, the size of cross-linked nano-assembly can be controlled in a wide range (
The performance of nanoparticles for biomedical application is highly dependent on their surface properties. The ability to functionalize the hydrophilic corona of polymersome allows one to optimize its performance and also expand the polymersome inventory for other potential applications. Pegylation of both cationic and anionic VesiGels were used to demonstrate the surface functionalization of hydrphoilic corona. NHS ester and amine terminated polyethylene glycol monomethyl ether were used to treat amino and carboxylate-containing VesiGel respectively. The successful peglation of the two types of VesiGels was confirmed by following their surface charges before and after the functionalization.
As shown in
It is desirable to control over the permeability of polymersomes to tune the mass transportation between media and polymersome lumen for the applications like nanoreactor or artificial organelles where the disruption of the vesicular structure is not desired. A potential solution to manipulate the transportation process can be tuning the hydrophobicity of vesicle wall by post-functionalization. This can also be an effective way to covalently incorporate the active components into the nanoassembly for therapeutic delivery applications. Independent functionalization of the hydrophilic corona and hydrophobic wall of the VesiGel would help demonstrate the versatility of the VesiGel platform for post-functionalization.
Taking the advantage of amino group and the left over pyridinyl disulfide, the VesiGel can be orthogonally functionalized with a FRET pair by reacting with the complementary isocynate containing rhodamine and thiol bearing fluorescein. The functionalization permanently immobilized rhodamine onto the corona with a thiourea linkage, but fluorescein onto hydrophobic wall with a cleavable disulfide bond. Concurrent observation of the absorbance of both dyes and FRET after extreme dialysis suggests the success of the functionalization (
To further test the difference on the reversibility of the two chemistries applied for functionalization, the VesiGel was treated with DTT which selectively cleave fluorescein from the nanoparticle. It was envisioned that the cleavage of fluorescein will result in precipitation out from solution, therefore, the decrease of absorbance while the absorbance of rhodamine remains the same because it still attached. This was indeed observed. The increase in the emission of fluorescein after the addition of DTT also indicated the cleavage of fluorescein. The increasing fluorescence can be attributed to the disappearance of FRET due to the lack of proximity between rhodamine and fluorescein molecules. Another possible reason for the fluorescence recovery of fluorescein can be due to the decrease in self-quenching of fluorescein after cleavage from VesiGel. All these observations suggest orthogonal functionalization of hydrophilic corona and hydrophobic wall can be done on the disclosed VesiGel.
The amphiphilicity of polymer allows the nano-assembly to encapsulate guest molecules. Due to the disulfide functionality in the nano-assembly, it should have responsiveness toward applied trigger, reductant, which reduces the disulfide bond and destabilizes the nano-assembly causing the release of loaded guest molecules. The ross-linked nano-assemblies are indeed found to release the loaded guest molecule when a redundant was added into nano-assembly solution (
The unique structural features having hydrophobic wall and hydrophilic lumen simultaneously, gives the polymersome the capability of serving as a reservoir for both hydrophobic and hydrophilic cargos. Bearing this structural characteristic along with the disulfide crosslinks, the disclosed VesiGels are expected to be able to encapsulate hydrophilic and hydrophobic cargos and have features of redox-triggered cargo release. Initially, DiI, a hydrophobic dye was encapsulated in VesiGels. The release of DiI was observed in the presence of DTT, which disrupts the VesiGel by breaking the disulfide crosslinks (
To test the ability to load the hydrophilic cargos, cationic and anionic VesiGels was formed in rodamine 6G and calcein solution respectively, where the hydrophilic cargos were expected to be engulfed into the cavity of polymersome in situ. So, even after the extensive dialysis, the local concentration of dye in VesiGel lumen is the same as that of the original dye solution which is high enough for self-quenching. Fluorescence recovery from both cationic and anionic VesiGels was observed upon the treatment of DTT (
Formulating the biomacromolecules into nanostructure for therapeutic or catalysis application is of much more interest. Here, myoglobin (Mw: 17 kDa, pI: 7.2) was chosen as a model protein to load into cationic VesiGels following the same procedure of rhodamine 6G encapsulation. As shown in
The success of encapsulation was evident by the observation of tyrosine absorption and emission. The release of pepsin triggered by the DTT was demonstrated by trypsin digestion assay detected by mass spectrometry. The basic design on this assay is that pepsin is prevented from being digested when it is trapped inside an intact VesiGel, while the disruption of VesiGel by DTT makes the pepsin accessible for digestion.
In
Thus, the invention discloses a general methodology for the preparation of size-tunable VesiGel platform directly from synthetically easily accessible homopolymers aqueous solution in the assistance of multivalent counter ions via salt-bridging mechanism. This method provides a variety of physical and chemical properties including: i) variable surface functionalities: ii) capability of simultaneous encapsulation of hydrophilics and hydrophobics; iii) engineerable corona and membrane; iv) redox-modulated programmable host-guest property into a single VesiGel system. The simplicity and versatility of this method to prepare VesiGel with engineerable properties will profoundly facilitate and extend the applications of the vesicular nanostructures.
As disclosed herein, instead of using copolymers with complex architectures, typically block copolymers, simple homopolymers are used as polymersome precursor synthetically saving tremendous efforts on polymer preparation. The targeted polymers are amphiphilic homopolymers comprised of a hydrophilic head group (amino or carboxylate) and a hydrophobic and cross-linkable group (pyrdinyl disulfide), as shown in
Thus, the approach takes advantage of the fidelity of the thiolatone ring opening reaction to prepare amphiphilic homopolymer. (Reinicke, et al. 2013 ACS Macro Lett. 2, 539-543; Espeel, et al. 2012 Polym. Chem. 3, 1007-1015.) The ring opening reaction of poly (thiolactone acrylamide) (PT1a) homopolymer was initiated by N-Boc ethylenediamine or β-alanine t-butyl ester generating an amide and thiol which was captured by excessive amount of aldrithiol in situ. Removal of protecting group by TFA gives the targeted amphiphilic homopolymers bearing ionic head groups and crosslinkable hydrophobic disulfide tails.
Single tailed small molecule surfactants with opposite charges that normally form micelles have been mixed at appropriate ratio to construct so-called “catanionic” vesicles. (Segota, et al. 2006 Adv. Colloid Interface Sci. 121, 51-75; Iampietro, et al. 1998 J. Phys. Chem. B. 102, 3105-3113.) Besides, multivalent counter ions have also been employed to induce the formation of vesicular structures. (Lee, et al. 2013 Soft Mater 9, 200-207; Li, et al. 2014 Adv. Funct. Mater. DOI: 10.1002/ADFM.201400569.) The formation of vesicular structure is attributed to the reduction in the area of hydrophilic head group due to the counter ion pairing changing the molecular packing parameters.
The herein disclosed approach takes advantage of the interaction between polyions and their counter ions to modulate the self-assemble process. The addition of divalent counterions adjusts the hydrophilic lipophilic balance of the homopolymer, along with the molecular packing parameters, to adopt the vesicular type assembly. The cationic homopolymer, P1 was found to form polymersomes in Na2HPO4 solution with a low millimolar salt concentration. The size of polymersomes readily increases from 40 nm to 90 nm when the concentration of Na2HPO4 increases from 1.5 mM to 2.5 mM (shown in SP).
The assembled polymersome can be further covalently stabilized by intraparticle disulfide crosslinking to lock the vesicular morphology. The size of VesiGel, shown in
Similarly, when anionic polymer, P2 was used as a precursor, MgCl2 can be used to induce the formation of anionic polymersome, which was confirmed by TEM. The size of obtained anionic polymersome was also found to be MgCl2 concentration dependant. Tunable size ranging from 45 nm to 120 nm was obtained when concentration of MgCl2 was increased from 2.4 mM to 4.8 mM. The crosslinking of anionic polymersome was also intra-particular indicated by the observation of similar particle size after and before crosslinking.
To further confirm VesiGels do have vesicular structure, radius of gyration (Rg) of the VesiGels prepared in 2.4 mM and 4.8 mM MgCl2 solution were by SLS to compare with their hydrodynamic radius (Rh) obtained from DLS. It turns out that Rg/Rh of VesiGels prepared in 2.4 mM and 4.8 mM is respectively measured to 1.19 and 0.99. The measured Rg/Rh values are closed to 1.0, which is the theoretical value for a vesicle. (Benoit, H., Froehlich, Light scattering from polymer solutions, edited by Huglin, M. B. (Academic Press, London, 1972).) A larger Rg/Rh value for small VesiGels prepared in 2.4 mM MgCl2 solution indicates a loose vesicular structure that was also confirmed by the blurred structure from TEM image.
To test if salt-induced formation of the polymersome can be generally applied, a variety of salts were employed to polymer solution followed by the measurement of the size of the nanoassembly. The size of nanoassembly from P1 in the presence of Na2SO4, Na2S2O3, and Na2SO3 was found to be significantly affected by the salt species (
In addition to these divalent salts, the effect of monovalent salts on self-assembly of both polymers was also investigated. Nanostructures around 6 nm were obtained in the presence of monovalent salts. These nanostructures with much smaller size are likely single chain nanoparticles due to the polymer chain collapse after cross-linking. It is worth noting that the concentration of monovalent salts used in both case are much higher than that of divalent salts (4-5 times). It is clear that the salts having divalent counter ions to corresponding polymers remarkably affect their self-assembly. Along with the lack of influence of monovalent salts on polymer assembly, the observation of divalent counterions mediated self-assembly suggests that operating mechanism of polymersome formation assisted by these salts can potentially be through salt-bridging.
It was proposed that the divalent counter ion interacts with two hydrophilic head groups of the polymer reducing the hydrophilicity of the polymer, consequently adjusting the packing parameters to meet the requirement for polymersome formation. On the other hand, salt-bridging also stabilize the lamellar packing of polymer chains on the vesicle wall. This hypothesis is also supported by the observation of salt-bridging induced morphological transformation of block copolymer assemblies from micelle to vesicle. (Zhang, et al. 1996 Science, 272, 1777-1779; Zhang, et al. 1996 Macromolecules 29, 8805-8815.) However, the proposed salt-bridging mechanism was not yet systematically investigated.
To test this theory, the polyions were mixed with a water-soluble dye, as a substitute of salt, which has multivalent counter ions to interact with the polymer. As shown in
Interestingly, excimer emission was observed from dimerized pyrene due to the proximity of the probe in polymer nanoaggregate. In addition, the lack of observation of the absorbance red shifting and fluorescence quenching of probes when polyions are mixed with probes of the same charge further supported the electrostatics-based hypothesis (
To further test this theory, a salt competition experiment was also performed, in which change on absorbance and fluorescence of a pre-mixed P1/calcein solution was followed, when the solution was titrated by Na2SO4. Here, it was envisioned that sulfate anions act as a competetiver binder with the cationic polymer and liberating the calcein probe from polymer/calcein complex, therefore, changing the photophysical properties of the probe. As released from the complex, the maximum absorption of calcein will be gradually blue shifted to its original one when it is completely freed from the complex. This was indeed observed and the data are shown in
Polymer stock solution preparation. 15 mg of P1 or P2 was directly dissolved in 2 mL of milliQ water. To make P2 dissolved, 1.5 eq. of NaOH was added to the solution. The obtained solution was then dialyzed against DI water using membrane with a MWCO of 3500 Da. The final concentration of solution was fixed to 5 mg/mL.
Polymersome and VesiGel formation. Calculated amount of salt stock solution (100 mM) was added to 300 μL of milliQ water. To the above slat solution, 200 μL of P1 stock solution was added to make final polymer solution with a concentration of 2 mg/mL. For P2, 400 μL of salt solution was prepared and added with 100 μL of P2 stock solution giving the polymer solution with a concentration of 1 mg/mL. The final polymer solutions were left for 3 hours to form polymersomes. The VesiGels were obtained by cross-linking the polymersome solution through the addition of calculated amount of DTT. The cross-linking reaction was allowed to undergo for 4 hours. The VesiGel was then purified by dialysis against water.
Guest molecules encapsulation. For hydrophobic guest encapsulation, 1 wt % of guest solution (1 mg/mL) in acetone was added to the polymersome solutions followed by the addition of DTT. The unloaded guest molecule was removed by filtration using syringe filter with a pore size of 0.4 μm. The hydrophilic guests were dissolved in the salt solution with a desired salt and guest concentration. To the solution, polymer stock solutions were added to form polymersomes which encapsulate the hydrophilic guest in situ. The free guest was removed by extensive dialysis against water after DTT crosslinking.
15 mg of P1 or P2 was directly dissolved in 2 mL of milliQ water. To make P2 dissolved, 1.5 eq. of NaOH was added to the solution. The obtained solution was then dialyzed against DI water using membrane with a MWCO of 3500 Da. The final concentration of solution was fixed to 5 mg/mL by adding milli Q water.
Calculated amount of salt stock solution (100 mM) was added to 300 uL of milliQ water. To the above salt solution, 200 μL of P1 stock solution was added to make final polymer solution with a concentration of 2 mg/mL. For P2, 400 uL of salt solution was prepared and added with 100 μL of P2 stock solution giving the polymer solution with a concentration of 1 mg/mL. The final polymer solutions were left for 3 hours to form polymersomes. The VesiGels were obtained by cross-linking the polymersome solution through the addition of calculated amount of DTT. The cross-linking reaction was allowed to take place for 4 hrs. The VesiGel was then purified by dialysis against water.
For hydrophobic guest encapsulation, 1 wt % of guest solution (1 mg/mL) in acetone was added to the polymersome solutions followed by the addition of DTT. The unloaded guest molecule was removed by filtration using syringe filter with a pore size of 0.4 um. The hydrophilic guests were dissolved in the salt solution with a desired salt and guest concentration. To the solution, polymer stock solutions were added to form polymersomes which encapsulate the hydrophilic guest in situ. The free guest was removed by extensive dialysis against water after DTT crosslinking.
2 mg/mL of myoglobin was dissolved in 1 mL of milliQ water. 11 μL of Na2HPO4 solution (100 mM) was added to 289 μL of myoglobin solution. 100 μL of P1 solution was added to myoglobin-Na2HPO4 solution followed by the addition of 0.1 equivalent of DTT after 2 hrs. The free myoblobin was removed 4 hrs later after the addition of DTT by dialysis against water using membrane with MWCO of 100 kDa.
10 mg of lysozyme was dissolved in 1 mL of milliQ water. 21 μL of MgCl2 solution (100 mM) was added to 379 μL of lysozyme solution. Then, 100 μL of P2 solution was added into lysozyme-MgCl2 solution followed by the addition of 0.1 eq of DTT after 2 hrs. The cross-linking reaction was allowed to undergo for 4 hrs. The unloaded lysozyme was removed by extensively dialysis against water using membrane with MWCO of 100 kDa.
VesiGel functionalization. Cationic VesiGel solution was added to 1 mL of DMSO solution. Then, the solution was adjusted to pH 9 by the addition of NaHCO3 solution. Then 0.2 equivalent of TRITC (to the amine) in DMSO was added to the nanoparticle solution. After 24 hours, 0.2 eq. thiol functionalized fluorescein solution in DMSO was also added to the reaction mixture. The reaction mixture was dialysis against MeOH using membrane with MWCO of 11000 Da.
PEGylation of cationic VesiGel. To 500 uL of 2 mg/mL cationic VesiGel solution (0.0022 mmol repeat unit), 500 μL of DMSO was added with 0.95 μL of triethylamine (0.0066 mmol, 3 eq.). 8.8 mg (0.0044 mmol, 2 eq.) of PEG-NHS ester (Mn: 2000 Da) was dissolved in 500 μL of DMSO and then added to the VesiGel solution. The reaction was allowed to go overnight. The free PEG was removed by dialysis against water.
PEGylation of anionic VesiGel. To 2 mL of 1 mg/mL of anionic VesiGel solution (0.0054 mmol repeat unit), 2.07 mg EDC (0.0108 mmol, 2 eq.) was added. Then, 6 mg (0.0108 mmol, 2 eq.) of PEG-NH2 (Mn: 550 Da) in 500 μL of water solution was added to VesiGel solution. The reaction was kept for 24 hrs. The free PEG was removed by dialysis against water.
In this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural reference, unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood too one of ordinary skill in the art. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art. Methods recited herein may be carried out in any order that is logically possible, in addition to a particular order disclosed.
References and citations to other documents, such as patents, patent applications, patent publications, journals, books, papers, web contents, have been made in this disclosure. All such documents are hereby incorporated herein by reference in their entirety for all purposes. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material explicitly set forth herein is only incorporated to the extent that no conflict arises between that incorporated material and the present disclosure material. In the event of a conflict, the conflict is to be resolved in favor of the present disclosure as the preferred disclosure.
The representative examples are intended to help illustrate the invention, and are not intended to, nor should they be construed to, limit the scope of the invention. Indeed, various modifications of the invention and many further embodiments thereof, in addition to those shown and described herein, will become apparent to those skilled in the art from the full contents of this document, including the examples and the references to the scientific and patent literature included herein. The examples contain important additional information, exemplification and guidance that can be adapted to the practice of this invention in its various embodiments and equivalents thereof.
This application claims the benefit of U.S. Provisional Application No. 61/886,016, filed Oct. 2, 2013, the entire content of which is incorporated herein by reference in its entirety.
The United States Government has certain rights to the invention pursuant to Grant No. CHE-1307118 from National Science Foundation (NSF), and Grant No. 5RO1GM065255 from National Institutes of Health (NIH), Grant No. W911NF1010313 from U. S. Army Research Office, Grant No. CMMI-1025020 from NSF-NSEC and Grant No. DMR-0820506 from NSF-MRSEC.
| Number | Date | Country | |
|---|---|---|---|
| 61886016 | Oct 2013 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15025060 | Mar 2016 | US |
| Child | 17390912 | US |
